The p16INK4A protein is a CDK (cyclin-dependent kinase) inhibitor, and it functions as a predominant suppressor of melanoma (Krimpenfort et al., 2001; Sviderskaya et al., 2002; Goldstein et al., 2006; Bennett, 2015). Here, CDKN2A is linked to melanoma.